• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

采用综合系统疫苗学方法的2019冠状病毒病疫苗接种图谱

COVID-19 vaccination atlas using an integrative systems vaccinology approach.

作者信息

Prates-Syed Wasim Aluísio, Fonseca Dennyson Leandro Mathias da, Pour Shahab Zaki, Lira Aline, Cortes Nelson, Silva Jaqueline Dinis Queiroz, Carvalho Evelyn, Filgueiras Igor Salerno, Vinces Tania Geraldine Churascari, Schimke Lena F, Chaves Lorena C S, Wunderlich Gerhard, Durães-Carvalho Ricardo, Dias Haroldo Dutra, Ochs Hans D, Câmara Niels O S, Nakaya Helder I, Krieger José E, Cabral-Marques Otavio, Cabral-Miranda Gustavo

机构信息

Institute of Tropical Medicine, Faculty of Medicine of the University of São Paulo, São Paulo, Brazil.

Institute of Biomedical Sciences (ICB), University of São Paulo (USP), São Paulo, Brazil.

出版信息

NPJ Vaccines. 2025 Jun 2;10(1):111. doi: 10.1038/s41541-025-01148-3.

DOI:10.1038/s41541-025-01148-3
PMID:40456760
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12130191/
Abstract

The COVID-19 vaccinations have played a significant role in controlling the pandemic. To elucidate their impact on the immune system, a COVID-19 vaccination atlas was developed using an integrative systems vaccinology approach. The atlas includes 562 samples from 245 participants, including both healthy individuals and those infected with or without prior vaccination, and covers the administration of five vaccines in different regimens. Key findings include the identification of distinct immune markers that differentiate between vaccine types and infection statuses. We observed that mRNA vaccines induced transient but strong immune responses after booster doses, whereas viral vector vaccines showed sustained immune activation with infection, partially resembling the immune profile exhibited during infection. Heterologous vaccination regimens demonstrated enhanced immune diversification compared to homologous regimens. Finally, we described the immunological landscape of COVID-19 vaccines and vaccines against other pathogens, at the gene-level and in cell population dynamics.

摘要

新冠疫苗在控制疫情方面发挥了重要作用。为阐明其对免疫系统的影响,采用综合系统疫苗学方法绘制了新冠疫苗图谱。该图谱包含来自245名参与者的562个样本,包括健康个体以及有或无既往接种史的感染者,涵盖了五种不同接种方案的疫苗接种情况。主要发现包括识别出区分疫苗类型和感染状态的不同免疫标志物。我们观察到,mRNA疫苗在加强剂量后诱导出短暂但强烈的免疫反应,而病毒载体疫苗在感染时表现出持续的免疫激活,部分类似于感染期间呈现的免疫特征。与同源接种方案相比,异源接种方案显示出更强的免疫多样性。最后,我们在基因水平和细胞群体动态方面描述了新冠疫苗以及针对其他病原体的疫苗的免疫格局。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3080/12130191/d24aa5f7b9a7/41541_2025_1148_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3080/12130191/a04fcb72223f/41541_2025_1148_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3080/12130191/4cfca60ac275/41541_2025_1148_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3080/12130191/b0653ffe6ecc/41541_2025_1148_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3080/12130191/cce62a5367d9/41541_2025_1148_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3080/12130191/92431fd07be3/41541_2025_1148_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3080/12130191/800dca47e4e6/41541_2025_1148_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3080/12130191/d24aa5f7b9a7/41541_2025_1148_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3080/12130191/a04fcb72223f/41541_2025_1148_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3080/12130191/4cfca60ac275/41541_2025_1148_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3080/12130191/b0653ffe6ecc/41541_2025_1148_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3080/12130191/cce62a5367d9/41541_2025_1148_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3080/12130191/92431fd07be3/41541_2025_1148_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3080/12130191/800dca47e4e6/41541_2025_1148_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3080/12130191/d24aa5f7b9a7/41541_2025_1148_Fig7_HTML.jpg

相似文献

1
COVID-19 vaccination atlas using an integrative systems vaccinology approach.采用综合系统疫苗学方法的2019冠状病毒病疫苗接种图谱
NPJ Vaccines. 2025 Jun 2;10(1):111. doi: 10.1038/s41541-025-01148-3.
2
Effective cellular and neutralizing immunity against SARS-CoV-2 after mRNA booster vaccination is associated with pDC and B cell activation.mRNA加强疫苗接种后对SARS-CoV-2产生有效的细胞免疫和中和免疫与浆细胞样树突状细胞(pDC)和B细胞活化有关。
Front Immunol. 2025 May 12;16:1580448. doi: 10.3389/fimmu.2025.1580448. eCollection 2025.
3
Pivoting to protein: the immunogenicity and safety of protein-based NVX-CoV2373 as a heterologous booster for inactivated and viral vector COVID-19 vaccines.转向蛋白质:基于蛋白质的 NVX-CoV2373 作为灭活和病毒载体 COVID-19 疫苗异源加强针的免疫原性和安全性。
Expert Rev Vaccines. 2023 Jan-Dec;22(1):620-628. doi: 10.1080/14760584.2023.2232020.
4
Evaluation of the safety and immunogenicity of different COVID-19 vaccine combinations in healthy individuals: study protocol for a randomized, subject-blinded, controlled phase 3 trial [PRIBIVAC].不同 COVID-19 疫苗组合在健康个体中的安全性和免疫原性评估:一项随机、设盲、对照的 3 期临床试验 [PRIBIVAC] 的研究方案。
Trials. 2022 Jun 16;23(1):498. doi: 10.1186/s13063-022-06345-2.
5
Kinetics and Persistence of the Cellular and Humoral Immune Responses to BNT162b2 mRNA Vaccine in SARS-CoV-2-Naive and -Experienced Subjects: Impact of Booster Dose and Breakthrough Infections.在 SARS-CoV-2 初免和既往感染人群中,BNT162b2 mRNA 疫苗对细胞和体液免疫应答的动力学和持久性:加强针和突破性感染的影响。
Front Immunol. 2022 May 31;13:863554. doi: 10.3389/fimmu.2022.863554. eCollection 2022.
6
Humoral and cellular immune durability of different COVID-19 vaccine platforms following homologous/heterologous boosters: one-year post vaccination.同源/异源加强接种后不同新冠疫苗平台的体液免疫和细胞免疫持久性:接种后一年
Front Immunol. 2025 Jan 22;16:1526444. doi: 10.3389/fimmu.2025.1526444. eCollection 2025.
7
T and B cell responses in different immunization scenarios for COVID-19: a narrative review.COVID-19不同免疫方案中的T细胞和B细胞反应:一项叙述性综述
Front Immunol. 2025 Mar 18;16:1535014. doi: 10.3389/fimmu.2025.1535014. eCollection 2025.
8
Anti-SARS-CoV-2 spike IgG following injection of the third dose vaccine: A systematic review with meta-analysis of heterologous versus homologous vaccination.接种第三剂疫苗后针对 SARS-CoV-2 刺突蛋白 IgG 的反应:异源与同源疫苗接种的系统评价与荟萃分析。
Front Public Health. 2023 Jan 12;10:960598. doi: 10.3389/fpubh.2022.960598. eCollection 2022.
9
MVA-based SARS-CoV-2 vaccine candidates encoding different spike protein conformations induce distinct early transcriptional responses which may impact subsequent adaptive immunity.编码不同刺突蛋白构象的基于MVA的新型冠状病毒2型候选疫苗可诱导不同的早期转录反应,这可能会影响随后的适应性免疫。
Front Immunol. 2024 Dec 19;15:1500615. doi: 10.3389/fimmu.2024.1500615. eCollection 2024.
10
Safety and immunogenicity following a homologous booster dose of a SARS-CoV-2 recombinant spike protein vaccine (NVX-CoV2373): a secondary analysis of a randomised, placebo-controlled, phase 2 trial.同源加强接种 SARS-CoV-2 重组刺突蛋白疫苗(NVX-CoV2373)的安全性和免疫原性:一项随机、安慰剂对照、2 期临床试验的二次分析。
Lancet Infect Dis. 2022 Nov;22(11):1565-1576. doi: 10.1016/S1473-3099(22)00420-0. Epub 2022 Aug 10.

引用本文的文献

1
VaxGO: an interactive web tool for systems vaccinology data analysis.VaxGO:一个用于系统疫苗学数据分析的交互式网络工具。
Bioinform Adv. 2025 May 2;5(1):vbaf101. doi: 10.1093/bioadv/vbaf101. eCollection 2025.

本文引用的文献

1
Complex heatmap visualization.复杂热图可视化。
Imeta. 2022 Aug 1;1(3):e43. doi: 10.1002/imt2.43. eCollection 2022 Sep.
2
Long non-coding RNAs and immune cells: Unveiling the role in viral infections.长非编码 RNA 与免疫细胞:在病毒感染中的作用。
Biomed Pharmacother. 2024 Jan;170:115978. doi: 10.1016/j.biopha.2023.115978. Epub 2023 Dec 5.
3
Immunity Induced by Inactivated SARS-CoV-2 Vaccine: Breadth, Durability, Potency, and Specificity in a Healthcare Worker Cohort.灭活新冠病毒疫苗诱导的免疫:医护人员队列中的广度、持久性、效力和特异性
Pathogens. 2023 Oct 18;12(10):1254. doi: 10.3390/pathogens12101254.
4
Long-term effectiveness of COVID-19 vaccines against infections, hospitalisations, and mortality in adults: findings from a rapid living systematic evidence synthesis and meta-analysis up to December, 2022.COVID-19 疫苗对成年人感染、住院和死亡的长期有效性:截至 2022 年 12 月快速实时系统证据综合和荟萃分析的结果。
Lancet Respir Med. 2023 May;11(5):439-452. doi: 10.1016/S2213-2600(23)00015-2. Epub 2023 Feb 10.
5
Immunogenicity Characterization of COVID-19 Vaccines: A Systematic Review and Meta-analysis.COVID-19 疫苗的免疫原性特征:系统评价和荟萃分析。
Rev Soc Bras Med Trop. 2023 Jan 23;56. doi: 10.1590/0037-8682-0661-2022. eCollection 2023.
6
Transcriptome signatures preceding the induction of anti-stalk antibodies elicited after universal influenza vaccination.通用流感疫苗接种后诱导产生抗茎部抗体之前的转录组特征。
NPJ Vaccines. 2022 Dec 10;7(1):160. doi: 10.1038/s41541-022-00583-w.
7
Transcriptional atlas of the human immune response to 13 vaccines reveals a common predictor of vaccine-induced antibody responses.人类对 13 种疫苗的免疫反应转录图谱揭示了一种预测疫苗诱导抗体反应的共同指标。
Nat Immunol. 2022 Dec;23(12):1788-1798. doi: 10.1038/s41590-022-01328-6. Epub 2022 Oct 31.
8
The Immune Signatures data resource, a compendium of systems vaccinology datasets.免疫特征数据资源,系统疫苗学数据集纲要。
Sci Data. 2022 Oct 20;9(1):635. doi: 10.1038/s41597-022-01714-7.
9
Real-world study of the effectiveness of BBIBP-CorV (Sinopharm) COVID-19 vaccine in the Kingdom of Morocco.摩洛哥王国 BBIBP-CorV(国药)新冠病毒疫苗真实世界研究的有效性。
BMC Public Health. 2022 Aug 20;22(1):1584. doi: 10.1186/s12889-022-14016-9.
10
Origin, virological features, immune evasion and intervention of SARS-CoV-2 Omicron sublineages.奥密克戎亚系的起源、病毒学特征、免疫逃逸与干预。
Signal Transduct Target Ther. 2022 Jul 19;7(1):241. doi: 10.1038/s41392-022-01105-9.